Fetal outcomes following paternal or maternal 5-aminosalicylic acid (mesalazine) use

Researchers from Odense University Hospital and the University of Southern Denmark in Odense have published a large population-based comparative cohort study investigating fetal outcomes following paternal or maternal 5-aminosalicylic acid use. More information can be found here.